Success Stories: NIW Petition Approved for Postdoctoral Research Fellow in Ohio in the Field of Surgical Oncology
Client’s Testimonial:
Fantastic news! I would like to thank everyone at North America Immigration Law Group for helping me through this process. I will highly recommend your services to anyone in the same situation.
On May 5th, 2015 We Received EB-2 NIW (National Interest Waiver) Approval (Approval Notice) for a Postdoctoral Research Fellow in the Field of Surgical Oncology
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: Greece
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Ohio
Approval Notice Date: May 5th, 2015
Processing Time: 4 Months, 2 Days
The client that North America Immigration Law Group – WeGreened.com had the opportunity to work with in this case was a Postdoctoral Research Fellow from Greece. His work has focused specifically in the areas of cancer biomarkers, where he was worked to identify biomarkers that predict whether patients will benefit from surgery and whether they will respond to radiation and chemotherapy treatment administrated before surgery, as well as in the areas of endocrine surgery and robotic surgery. We successfully demonstrated that his continued employment in the field would benefit those in his field, as well as the citizens of the United States at large. In order for our client’s case to be successful, we submitted extensive documentation proving his highly significant contributions to his field, including 9 peer-reviewed journal articles and numerous conference papers. His publications had been cited at least 20 times at the time we filed the case; nearly all of the citations were by independent researchers around the world, demonstrating that these publications are widely recognized and relied upon in the field. The importance of his work was confirmed in the following quote from an independent recommender, “[Client] found that a patient's KRAS status more accurately predicted outcome than various other factors traditionally associated with survival such as tumor number, carcinoembryonic antigen, and primary stage. By identifying KRAS as a predictive biomarker, [Client] has provided to physicians a more accurate guideline when counseling patients as to their expected outcomes, as well as in determining the most appropriate treatment plan.” Through extensive documentation, we were able to successfully argue that our client would serve the national interest to a significantly greater degree than others with similar education and experience. His NIW petition was approved in 4 months and 2 days.